Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 1, 2013, Pages 51-58

  Power, Brian D ^a   Dragovic, Milan ^a   Jablensky, Assen ^a   Stefanis, Nikos C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Amphetamine; cannabis; cocaine; dopamine; psychosis; schizophrenia; sensitization

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MENTAL HOSPITAL; MENTAL PATIENT; ONSET AGE; OUTPATIENT; PREDICTOR VARIABLE; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SUBSTANCE ABUSE; TREND STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; AUSTRALIA; COCAINE-RELATED DISORDERS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; LINEAR MODELS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PRECIPITATING FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84873934226     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412461957     Document Type: Article

References (44)

1. Addington J, Addington D. Effect of substance misuse in early psychosis. British Journal of Psychiatry. 1998 ; 172: 134-136
2. Akimoto K, Hamamura T, Kazahaya Y, et al. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine: An in vivo dialysis study in freely moving rats. Brain Research. 1990 ; 507: 344-346
3. Akimoto K, Hamamura T, Otsuki S. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Research. 1989 ; 490: 339-344
4. Andreasson S, Allbeck P, Engstrom A, et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987 ; ii: 1483-1486
5. Australian Institute of Health and Welfare (2008) National Drug Strategy Household Survey - State and Territory Supplement 2008. Available at: www.aihw.gov.au/publication-detail/?id=6442468144 (accessed 16 November 2011).
6. Barnes TR, Mutsatsa SH, Hutton SB, et al. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry. 2006 ; 188: 237-242
7. Boileau I, Dagher A, Leyton M, et al. Modeling sensitization to stimulants in humans: An [11C]raclopride/positron emission tomography study in healthy men. Archives of General Psychiatry. 2006 ; 63: 1386-1395
8. Bossong MG, van Berckel BN, Boellaard R, et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology. 2009 ; 34: 759-766
9. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: A review of the literature and a study of correlates in Sweden. Schizophrenia Research. 2001 ; 48: 69-82
10. Carr VJ, Neil AL, Halpin SA, et al. Costs of schizophrenia and other psychoses in urban Australia: Findings from the Low Prevalence (Psychotic) Disorders Study. Australian and New Zealand Journal of Psychiatry. 2003 ; 37: 31-40
11. Castle D, Jablensky A, McGrath J, et al. The diagnostic interview for psychosis (DIP): Development, reliability and applications. Psychological Medicine. 2006 ; 36: 69-80
12. Centonze D, Rossi S, De Chiara V, et al. Chronic cocaine sensitizes striatal GABAergic synapses to stimulation of cannabinoid CB1 receptors. European Journal of Neuroscience. 2007 ; 25: 1631-1640
13. Chen CK, Lin SK, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine. 2003 ; 33: 1407-1414
14. Davis KL, Kahn RS, Ko G, et al. Dopamine in schizophrenia: A review and reconceptualization. American Journal of Psychiatry. 1991 ; 148: 1474-1486
15. DeLisi LE. The significance of age of onset for schizophrenia. Schizophrenia Bulletin. 1992 ; 18: 209-215
16. DeQuardo JR, Carpenter CF, Tandon R. Patterns of substance use in early psychosis. Journal of Psychiatric Research. 1994 ; 28: 267-275
17. Farrell M, Boys A, Bebbington P, et al. Psychosis and drug dependence: Results from a national survey of prisoners. British Journal of Psychiatry. 2002 ; 181: 393-398
18. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction. 2005 ; 100: 354-366
19. Gonzalez-Pinto A, Vega P, Ibanez B, et al. Impact of cannabis and other drugs on age at onset of psychosis. Journal of Clinical Psychiatry. 2008 ; 69: 1210-1216
20. Hallmayer JF, Kalaydjieva L, Badcock J, et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. American Journal of Human Genetics. 2005 ; 77: 468-476
21. Henquet C, Rosa A, Krabbendam L, et al. An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9- tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology. 2006 ; 31: 2748-2755
22. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III - the final common pathway. Schizophrenia Bulletin. 2009 ; 35: 549-562
23. Jablensky A. Subtyping schizophrenia: Implications for genetic research. Molecular Psychiatry. 2006 ; 11: 815-836
24. Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: An overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry. 2000 ; 34: 221-236
25. Keppel G Design and Analysis: A Researcher's Handbook. 1982 ) Design and Analysis: A Researcher's Handbook, second edition. Englewood Cliffs: Prentice-Hall. Englewood Cliffs: Prentice-Hall ; 1982 :
26. Konings M, Stefanis N, Kuepper R, et al. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychological Medicine. 2012 ; 42: 149-159
27. Kuepper R, van Os J, Lieb R, et al. Continued cannabis use and risk of incidence of psychotic symptoms: 10 year follow-up cohort study. British Medical Journal. 2001 ; 342: d738
28. Large M, Sharma S, Compton MT, et al. Cannabis use and earlier onset of psychosis. Archives of General Psychiatry. 2011 ; 68: 555-561
29. Laruelle M, Abi-Dargham A, van Dyck CH, et al. Single emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic patients. Proceedings of the National Academy of Science of the United States of America. 1996 ; 93: 9235-9240
30. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica. 2000 ; 101: 3-38
31. Luzi S, Morrison PD, Powell J, et al. What is the mechanism whereby cannabis use increases risk of psychosis?. Neurotoxicity Research. 2008 ; 14: 105-112
32. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry. 1991 ; 48: 764-770
33. Paparelli A, Di Forti M, Morrison PD, et al. Drug-induced psychosis: How to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Frontiers in Behavioral Neuroscience. 2011 ; 5: 1-9
34. Safont G, Corripio I, Escarti MJ, et al. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study. Schizophrenia Research. 2011 ; 129: 169-171
35. Sevy S, Robinson DG, Napolitano B, et al. Are cannabis use disorders associated with an earlier age at onset of psychosis?. Schizophrenia Research. 2010 ; 120: 101-107
36. Sevy S, Robinson DG, Solloway S, et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica. 2001 ; 104: 367-374
37. Stefanis NC, Delespaul P, Henquet C, et al. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004 ; 99: 1333-1341
38. Stokes PR, Mehta MA, Curran HV, et al. Can recreational doses of THC produce significant dopamine release in the human striatum. Neuroimage. 2009 ; 48: 186-190
39. Ujike H. Stimulant-induced psychosis and schizophrenia: The role of sensitization. Current Psychiatry Reports. 2002 ; 4: 177-184
40. Van Os J, Kenis G, Rutten B. The environment and schizophrenia. Nature. 2010 ; 468: 203-212
41. Van Rossum JM. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Archives Internationales de Pharmacodynamie et de Therapie. 1966 ; 160: 492-494
42. Veen ND, Selten J-P, van der Tweel I, et al. Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry. 2004 ; 161: 501-506
43. Voruganti LN, Slomka P, Zabel P, et al. Cannabis induced dopamine release: An in-vivo SPECT study. Psychiatry Research. 2001 ; 107: 173-177
44. Wade D, Harrigan S, Edwards J, et al. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research. 2006 ; 81: 145-150